Too much blood sugar, usually because of diabetes
Not to be confused with the opposite disorder (involving low blood sugar),
hypoglycemia .
Medical condition
Hyperglycemia Other names High blood sugar, hyperglycemia, hyperglycæmia Artist's depiction of hyperglycemia.
White hexagons in the image represent glucose molecules, which are increased in the lower image. Specialty Endocrinology
Hyperglycemia or hyperglycaemia is the situation in which blood glucose level is higher than in a healthy subject. A fasting healthy human shows blood glucose level up to 5.6 mmol/L (100 mg/dL). After a meal (postprandial ) containing carbohydrates, healthy subjects show postpandrial euglycemic peaks of less than 140 mg/dL (7.8 mmol/L).[ 1] [ 2] [ 3] [ 4] [ 5] [ 6] [ 7] Therefore, fasting hyperglycemia are values of blood glucose higher than 5.6 mmol/L (100 mg/dL) whereas postprandial hyperglycemia are values higher than 140 mg/dL (7.8 mmol/L).[ 2] [ 3] Postprandial hyperglycemic levels as high as 155 mg/dL (8.6 mmol/L) at 1-h are associated with T2DM-related complications, which worsen as the degree of hyperglycemia increases.[ 8] [ 9] [ 10] [ 11] Patients with diabetes are oriented to avoid exceeding the recommended postprandial threshold of 160 mg/dL (8.89 mmol/L) for optimal glycemic control.[ 12] [ 11] [ 13] Values of blood glucose higher than 160 mg/dL are classified as ‘very high’ hyperglycemia,[ 1] a condition in which an excessive amount of glucose (glucotoxicity) circulates in the blood plasma . These values are higher than the renal threshold of 180 mg/dL (10 mmol/L) up to which glucose reabsorption is preserved at physiological rates[ 8] [ 14] [ 15] and insulin therapy is not necessary.[ 16] [ 17] Blood glucose values higher than the cutoff level of 200 mg/dL (11.1 mmol/L) are used to diagnose T2DM[ 18] and strongly associated with metabolic disturbances,[ 19] although symptoms may not start to become noticeable until even higher values such as 13.9–16.7 mmol/L (~250–300 mg/dL ). A subject with a consistent fasting blood glucose range between ~5.6 and ~7 mmol/L (100–126 mg/dL ) (American Diabetes Association guidelines) is considered slightly hyperglycemic, and above 7 mmol/L (126 mg/dL ) is generally held to have diabetes . For diabetics, glucose levels that are considered to be too hyperglycemic can vary from person to person, mainly due to the person's renal threshold of glucose and overall glucose tolerance. On average, however, chronic levels above 10–12 mmol/L (180–216 mg/dL) can produce noticeable organ damage over time.
^ a b Biradar, Rajeshwari A.; Singh, Dharmendra P.; Thakur, Harshad; Halli, Shiva S. (July 2020). "Gender differences in the risk factors for high and very high blood glucose levels: A study of Kerala" . Diabetes & Metabolic Syndrome: Clinical Research & Reviews . 14 (4): 627–636. doi :10.1016/j.dsx.2020.05.001 . PMID 32422447 .
^ a b Moreira, Fernanda Duarte; Reis, Caio Eduardo Gonçalves; Gallassi, Andrea Donatti; Moreira, Daniel Carneiro; Welker, Alexis Fonseca (2024-10-09). Dardari, Dured (ed.). "Suppression of the postprandial hyperglycemia in patients with type 2 diabetes by a raw medicinal herb powder is weakened when consumed in ordinary hard gelatin capsules: A randomized crossover clinical trial" . PLOS ONE . 19 (10): e0311501. doi :10.1371/journal.pone.0311501 . ISSN 1932-6203 . PMC 11463819 . PMID 39383145 .
^ a b Monnier, L.; Colette, C.; Owens, D. (March 2021). "Application of medium-term metrics for assessing glucose homoeostasis: Usefulness, strengths and weaknesses" . Diabetes & Metabolism . 47 (2): 101173. doi :10.1016/j.diabet.2020.06.004 . PMID 32561428 .
^ Pazos-Couselo, Marcos; Portos-Regueiro, Cristina; González-Rodríguez, María; Manuel García-Lopez, Jose; Alonso-Sampredro, Manuela; Rodríguez-González, Raquel; Fernández-Merino, Carmen; Gude, Francisco (June 2022). "Aging of glucose profiles in an adult population without diabetes" . Diabetes Research and Clinical Practice . 188 : 109929. doi :10.1016/j.diabres.2022.109929 . PMID 35580705 .
^ American Diabetes Association Professional Practice Committee (2022-01-01). "2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2022" . Diabetes Care . 45 (Supplement_1): S17–S38. doi :10.2337/dc22-S002 . ISSN 0149-5992 .
^ Nakayama, Yuto; Ono, Kumiko; Okagawa, Junya; Urabe, Junji; Yamau, Ryoga; Ishikawa, Akira (2022-04-01). "Home-Based High-Intensity Interval Exercise Improves the Postprandial Glucose Response in Young Adults with Postprandial Hyperglycemia" . International Journal of Environmental Research and Public Health . 19 (7): 4227. doi :10.3390/ijerph19074227 . ISSN 1660-4601 . PMC 8998503 . PMID 35409907 .
^ Haschka, Stefanie J; Gar, Christina; Potzel, Anne L; Sacco, Vanessa; Kern-Matschilles, Stefanie; Benz, Irina; Then, Cornelia; Seissler, Jochen; Lechner, Andreas (2022-04-07). "A Normalized Real-Life Glucose Profile After Diet-Induced Remission of Type 2 Diabetes: A Pilot Trial" . Cureus . 14 (4). doi :10.7759/cureus.23916 . ISSN 2168-8184 . PMC 9076033 . PMID 35530849 .
^ a b Bergman, Michael; Abdul-Ghani, Muhammad; DeFronzo, Ralph A.; Manco, Melania; Sesti, Giorgio; Fiorentino, Teresa Vanessa; Ceriello, Antonio; Rhee, Mary; Phillips, Lawrence S.; Chung, Stephanie; Cravalho, Celeste; Jagannathan, Ram; Monnier, Louis; Colette, Claude; Owens, David (July 2020). "Review of methods for detecting glycemic disorders" . Diabetes Research and Clinical Practice . 165 : 108233. doi :10.1016/j.diabres.2020.108233 . PMC 7977482 . PMID 32497744 .
^ Bergman, Michael; Manco, Melania; Sesti, Giorgio; Dankner, Rachel; Pareek, Manan; Jagannathan, Ram; Chetrit, Angela; Abdul-Ghani, Muhammad; Buysschaert, Martin; Olsen, Michael H.; Nilsson, Peter M.; Medina, José Luis; Roth, Jesse; Groop, Leif; del Prato, Stefano (December 2018). "Petition to replace current OGTT criteria for diagnosing prediabetes with the 1-hour post-load plasma glucose ≥ 155 mg/dl (8.6 mmol/L)" . Diabetes Research and Clinical Practice . 146 : 18–33. doi :10.1016/j.diabres.2018.09.017 . PMID 30273707 .
^ Bergman, Michael (2021-09-07). "The 1-Hour Plasma Glucose: Common Link Across the Glycemic Spectrum" . Frontiers in Endocrinology . 12 . doi :10.3389/fendo.2021.752329 . ISSN 1664-2392 . PMC 8453142 . PMID 34557166 .
^ a b Chawla, Rajeev; Mukherjee, Jagat Jyoti; Chawla, Manoj; Kanungo, Alok; Shunmugavelu, Meenakshi Sundaram; Das, Ashok Kumar (2021-05-28). "Expert Group Recommendations on the Effective Use of Bolus Insulin in the Management of Type 2 Diabetes Mellitus" . Medical Sciences . 9 (2): 38. doi :10.3390/medsci9020038 . ISSN 2076-3271 . PMC 8162981 . PMID 34071359 .
^ Brand-Miller, Jennie C; Stockmann, Karola; Atkinson, Fiona; Petocz, Peter; Denyer, Gareth (January 2009). "Glycemic index, postprandial glycemia, and the shape of the curve in healthy subjects: analysis of a database of more than 1000 foods" . The American Journal of Clinical Nutrition . 89 (1): 97–105. doi :10.3945/ajcn.2008.26354 . PMID 19056599 .
^ Alyass, Akram; Almgren, Peter; Akerlund, Mikael; Dushoff, Jonathan; Isomaa, Bo; Nilsson, Peter; Tuomi, Tiinamaija; Lyssenko, Valeriya; Groop, Leif; Meyre, David (January 2015). "Modelling of OGTT curve identifies 1 h plasma glucose level as a strong predictor of incident type 2 diabetes: results from two prospective cohorts" . Diabetologia . 58 (1): 87–97. doi :10.1007/s00125-014-3390-x . ISSN 0012-186X . PMID 25292440 .
^ Cui, Shan-Shan; Duan, Li-Jun; Li, Jun-Feng; Qin, Yong-Zhang; Bao, Su-Qing; Jiang, Xia (November 2021). "The Factors Influencing the Renal Glucose Threshold in Patients with Newly Diagnosed Type 2 Diabetes Mellitus" . Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy . 14 : 4497–4503. doi :10.2147/DMSO.S336791 . ISSN 1178-7007 . PMC 8590450 . PMID 34785919 .
^ Hieshima, Kunio; Sugiyama, Seigo; Yoshida, Akira; Kurinami, Noboru; Suzuki, Tomoko; Ijima, Hiroko; Miyamoto, Fumio; Kajiwara, Keizo; Jinnouchi, Katsunori; Jinnouchi, Tomio; Jinnouchi, Hideaki (May 2020). "Elevation of the renal threshold for glucose is associated with insulin resistance and higher glycated hemoglobin levels" . Journal of Diabetes Investigation . 11 (3): 617–625. doi :10.1111/jdi.13191 . ISSN 2040-1116 . PMC 7232275 . PMID 31770476 .
^ American Diabetes Association Professional Practice Committee (2022-01-01). "6. Glycemic Targets: Standards of Medical Care in Diabetes—2022" . Diabetes Care . 45 (Supplement_1): S83–S96. doi :10.2337/dc22-S006 . ISSN 0149-5992 . PMID 34964868 .
^ American Diabetes Association (2022-01-01). "Standards of Medical Care in Diabetes—2022 Abridged for Primary Care Providers" . Clinical Diabetes . 40 (1): 10–38. doi :10.2337/cd22-as01 . ISSN 0891-8929 . PMC 8865785 . PMID 35221470 .
^ Gyberg, Viveca; De Bacquer, Dirk; Kotseva, Kornelia; De Backer, Guy; Schnell, Oliver; Tuomilehto, Jaakko; Wood, David; Rydén, Lars (December 2016). "Time-saving screening for diabetes in patients with coronary artery disease: a report from EUROASPIRE IV" . BMJ Open . 6 (12): e013835. doi :10.1136/bmjopen-2016-013835 . ISSN 2044-6055 . PMC 5168687 . PMID 27932342 .
^ Selvin, Elizabeth; Rawlings, Andreea; Lutsey, Pamela; Maruthur, Nisa; Pankow, James S.; Steffes, Michael; Coresh, Josef (2016-01-01). "Association of 1,5-Anhydroglucitol With Cardiovascular Disease and Mortality" . Diabetes . 65 (1): 201–208. doi :10.2337/db15-0607 . ISSN 0012-1797 . PMC 4686946 . PMID 26395741 .